.png){kind=icon}
S
Shi Zhao
H-index:45
Citation Count:1.0万
Views:0
Biography
No content for now.
Education
No content for now.
Work Experience
No content for now.
Honors & Awards
No content for now.
Real-world evaluation of Chinese National Maternal and Newborn Safety Action Plan for reducing neonatal mortality among pregnant women with conditions: a retrospective, matched, population-based cohort study
对中国国家母婴安全行动计划在降低合并症孕产妇新生儿死亡率中的实际效果评估：一项回顾性、匹配、基于人群的队列研究
Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation study
尼马曲韦/利托那韦和莫那比拉韦在降低新型冠状病毒肺炎短期和长期心血管并发症风险方面的有效性: 一项目标试验仿真研究
Nature Communications
IF15.7
Risk of unexpected newborn complications by day of the week and time of birth in US term singleton births
美国足月单胎分娩中，按星期几和分娩时间划分的新生儿意外并发症风险
Risk of HIV viral rebound after SARS-CoV-2 infection among people living with HIV on antiretroviral therapy: a retrospective matched cohort study
接受抗逆转录病毒治疗的HIV感染者中，SARS-CoV-2感染后HIV病毒反弹的风险：一项回顾性匹配队列研究
Associations of PM2.5 Carbonaceous and Ionic Constituents with Fractional Exhaled Nitric Oxide (FeNO): A Panel Study with 16 Follow-up Visits over 4 years
PM2.5碳质和离子组分与呼出气一氧化氮（FeNO）的关联性：一项为期4年、包含16次随访访问的队列研究
Greater benefits of immediate nirmatrelvir-ritonavir initiation for post-COVID outcomes: a population-based retrospective cohort study
Nirmatrelvir-ritonavir立即开始治疗对COVID后结果的更大益处: 一项基于人群的回顾性队列研究
Nature Communications
IF15.7
SARS-CoV-2 rebound and post-acute mortality and hospitalization among patients admitted with COVID-19: cohort study
新型冠状病毒肺炎患者的SARS-CoV-2反弹和急性后死亡率和住院: 队列研究
Nature Communications
IF15.7
Risk factors for recurrence after endoscopic papillectomy in ampullary adenomas: a retrospective case–control study
胆管壶腹腺瘤内镜下乳头切除术后的复发危险因素：一项回顾性病例对照研究
Post-pandemic excess mortality of COVID-19 in Hong Kong: a retrospective study
后疫情时代香港COVID-19超额死亡率：一项回顾性研究
Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID-19 outcomes among outpatients: a target trial emulation investigation
nirmatrelvir/ritonavir和molnupiravir对门诊患者的post-COVID-19结果的有效性: 目标试验仿真研究
